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Abstract Heat shock protein 70 (hsp70) has been detected in 
atherosclerotic lesions, in which endothelial cells and smooth mus- 
cle cells are involved. In a previous report we showed that Ox- 
LDL, a causal factor in atherosclerosis, could induce hsp70 ex- 
pression in cultured human endothelial cells [Zhn et al. B.B.R.C 
1994, 200: 389]. Here, with immunofluorescence and immunoblot- 
ting techniques, we show that Ox-LDL are capable of inducing 
hsp70 expression also in human smooth muscle cells, and that this 
induction is dependent on cell density and on the concentration 
of Ox-LDL. The induced expression of hsp70 was higher in 
human umbilical vein smooth muscle cells than in a human smooth 
muscle cell line. Conversely, Ox-LDL was eytotoxie to both types 
of cells, more so to the human smooth muscle cell line. These 
observations indicate that Ox-LDL may be a stress responsible 
for hsp70 expression in atherosclerotic plaques and the presence 
of hsp70 in plaques may be a useful marker for continuous oxida- 
tive damage in the arterial wall. 
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atheroma, we addressed the question whether Ox-LDL may 
represent a stress able to induce human smooth muscle cells to 
express hsp70. 
2. Materials and methods 
2.1. Cells 
Human umbilical vein smooth muscle cells (HUVSMC) were isolated 
as described [7]. In brief, the umbilical cord vein was cannulated atboth 
ends and rinsed with lactated Ringer's (Hartmann's) olution. Firstly, 
endothelial cells were removed by 0.1% collagenase incubation (10-20 
rain). Smooth muscle cells were then obtained by further treatment of 
the vein with 0.2% collagenase for 30-60 rain. Cells were collected by 
low speed centrifagation and grown at 37°C in a humidified atmos- 
phere of 5% CO2 in MEM supplemented with 10% (v/v) FCS, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 20 mM tricine buffer and 1% (v/v) 
non-essential mino acid solution. Cells were used between the I st and 
3rd passage. Smooth muscle cells were identified on the basis of their 
morphology and by mean ofa monoclonal ntibody specific for ~-actin, 
the actin isoform typical of smooth muscle cells [8]. A-617 SMC myo- 
cytes, a smooth muscle cell line derived from human femoral artery 
(kindly provided by Dr. G. Gabbiani, Geneva), were grown in the same 
conditions. 
1. Introduction 
Hyperthermia nd other toxic stimuli result in an increased 
production of stress proteins, or heat shock proteins (hsps). 
Hsps afford protection against proteotoxic factors by maintain- 
ing cellular proteins in their functional conformation [1] These 
inducible polypeptides have constitutive cognates, which, in 
physiological conditions, ensure the correct folding and target- 
ing of newly synthesized proteins [1]. Hsps are classified into 
several groups on the basis of molecular mass, and the 70 kDa 
hsps (hsp70) are the subject of extensive research because they 
are often highly induced in stressed cells and are thought to 
represent a basic feature of cell ability to cope with adverse 
conditions [2]. We previously reported that Ox-LDL, an impor- 
tant etiological factor of atherosclerosis, trigger the expression 
of the inducible form of hsp70 in cultured human endothelial 
cells [3]. Furthermore an increased expression of hsp70 has 
been observed in human atherosclerotic plaques [4~6]. Since 
smooth muscle cells are primarily involved in the formation of 
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vein smooth muscle cells; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyltetrazolium bromide; PBS, phosphate-buffered saline; PMSF, 
phenylmethylsulfonyl fluoride; PBST, phosphate-buffered 
saline + 0.1% Tween 20. 
2.2. Lipoproteins 
LDL were isolated by sequential ultracentrifugation from freshly 
drawn human plasma, containing 0.01% EDTA (w/v), [9]. Ac-LDL 
were prepared by repeated additions of acetic anhydride, according to 
Basu et al. [10], and Ox-LDL were prepared in the presence of 20 ,aM 
Cu z+, as described [11]. 
2,3. lmmunofluorescence 
Smooth muscle cells were grown on glass coverslips in 24-well culture 
plates and incubated with lipoproteins in fresh medium without FCS. 
Immunofluorescence staining procedure was the same as described [3]. 
Specific monoclonal antibodies to hsp70 (1:200) were used, followed 
by biotinylated anti mouse IgG (1:250) and by fluoresceinated strep- 
tavidin (1 : 100). The mouse monoclonal ntibody specific for the induc- 
ible form of hsp70 (C92F3A-5) was purchased from StressGen (Cana- 
da). Mouse monoclonal ntibodies specific for ~-actin and fl-actin (cy- 
toplasmic isoform) were purchased from Amersham (England). 
2.4. hnmunoblotting 
Cells were incubated with Ox-LDL at different concentrations for 12 
h, then lysed in TRIS buffer containing SDS (3%) and PMSF (1 mM); 
protein was determined according to Lowry et al. [12], and equal 
amounts of protein from the different samples were subjected to SDS- 
PAGE on a 10% gel, after the addition of fl-mercaptoethanol (2%), 
glycerol and bromophenol b ue. Electrophoresed proteins were trans- 
ferred onto a nitrocellulose membrane using a trans blot cell (Bio-Rad, 
USA) [13]. The membrane was incubated with PBS/3% BSA (blocking 
buffer) for 1 h at 25°C, then with PBS/0.1% Tween-20 (PBST) contain- 
ing anti hsp70 mouse monoclonal antibody (C92F3A-5) for 1 h. After 
3 washes with PBST, the membrane was incubated for 1 h in PBST 
containing a secondary antibody (goat anti-mouse IgG conjugated with 
peroxidase, Amersham, 1:2000). The membrane was washed in PBST 
and the immunocomplex was detected by an enhanced chemilumines- 
cence method (ECL, Amersham). 
2.5. Cell viabili O, 
Cell viability was evaluated by the MTT test [14]. Cells (30,000/well) 
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Fig. 1. Hsp70 induction by Ox-LDL in human umbilical vein smooth muscle cells (HUVSMC). Cells incubated without lipoproteins, as a control 
(a, × 1350); cells incubated with native LDL (200/~g/ml) for 12 h (b, × 1350); cells were incubated with Ox-LDL (200/.tg/ml) for 12 h (c, × 350); cells 
were incubated with Ox-LDL plus cycloheximide (4~ug/ml) for 12 h (d, × 1350); confluent cells incubated with Ox-LDL for 12 h (e, ×350); confluent 
cells were considered with a Teftlon policeman, allowed to recover for 24 h and incubated with Ox-LDL for 12 h (f, ×350); panel (f) depicts both 
cells healing the lesion (left), displaying strong hsp70 staining, and confluent cells (right), displaying very faint staining. Arrows indicate the edge 
of the lesion. For experimental details refer to section 2. 
in 12-well culture plates were incubated for 12 h in serum-free medium 
containing Ox-LDL (200 fig protein/ml), then incubated for 3 h in 
phenol red free-RPMI containing MTT (1 mg/ml). Isopropanol was 
used to dissolve transformed MTT and the absorbance at560 nm was 
measured using an automatic plate reader (Titertek Multiscan 2). Cell 
viability was expressed as percent ratio over viable control cells, incu- 
bated in the presence of BSA (200/lg/ml). 
3. Results 
H UVSMC showed almost no staining when probed with the 
anti hsp70 ant ibody after an incubation in l ipoprotein-free me- 
dium (Fig. la) or in medium containing native LDL (Fig. lb). 
When non confluent HUVSMC were incubated with Ox-LDL 
(200/.tg protein/ml) for 12 h, there was an intense, cytoplasmic 
staining revealing the expression of hsp70 (Fig. lc); when the 
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Fig. 2. lmmunoblotting analysis of hsp70 in HUVSMC. Proliferating 
cells in sparse culture were incubated in the absence (lane 1) or in the 
presence of Ox-LDL (100, 200, 400 pg/ml, lanes 2-4) for 12 h. Cellular 
proteins (15/1g/lane) were separated by 10% SDS-PAGE and electro- 
transferred onto a nitrocellulose membrane. The inducible form of 
hsp70 was detected by mean of a specific antibody, as described in 
section 2. 
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Fig. 3. Hsp70 induction by Ox-LDL and staining for ~- and fl-actin isoforms in HUVSMC (c,d,e,g) and in the A-617 SMC line (a,b,f,h). A-617 SMC 
line incubated with no lipoproteins, as a control (a, x 1350) and with Ox-LDL (400 ,ug/ml) for 12 h (b, x 1350); HUVSMC incubated with no 
lipoproteins, as a control (c, x 1350) and with Ox-LDL (400/~g/ml) for 12 h (d, x 1350); HUVSMC and A-617 SMC line probed with anti-c~-actin 
antibody (e,f, x 1350); HUVSMC and A-617 SMC line probed with anti-fl-actin antibody, (g.h, x 1350). For experimental details refer to section 2. 
cells were incubated with Ox-LDL plus cycloheximide (4/ lg/  
ml), a protein systhesis inhibitor, the expression of hsp70 was 
suppressed (Fig. ld). Thus, hsp70 induction by Ox-LDL was 
dependent on protein systhesis. As we observed with human 
endothelial cells [3], the induction of hsp70 expression by 
OxLDL in confluent HUVSMC was much lower than in non- 
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Fig. 4. Ox-LDL cytotoxicity o human smooth muscle cells (HUVSMC 
and the A-617 SMC line). Sparsely grown cells (30,000 cells/well) were 
incubated with Ox-LDL, Ac-LDL, native LDL (200/lg/ml) for 24 h. 
Viability was determined by the MTT test, as described insection 2, and 
expressed as percent of control cells, incubated in medium containing 
BSA (flg/ml). Values are the mean + S.D. of 3 separate determinations. 
*P < 0.01 vs. control; nP < 0.05 vs. Ox-LDL group of HUVSMC. 
confluent cells (compare fig lc and Fig. le). In order to under- 
stand why sparse and confluent cells have different responses 
to Ox-LDL, we performed a wounding experiment. A confluent 
culture of HUVSMC was wounded with a Teflon policeman 
and cells were allowed to recover in fresh medium for 24 h. 
Starting at this time, cells were incubated with Ox-LDL (400 
~g/ml) for 12 h and subsequently stained for hsp70. Only cells 
healing the lesion displayed hspV0 staining, while staining of 
confluent cells was very faint (Fig. 1 f). This result indicated that 
actively dividing or/and migrating cells, involved in wound re- 
pair, as sparse cells are likely to be, were more sensitive to 
Ox-LDL than relatively quiescent and stationary cells. Further- 
more, immunoblotting results also indicated that the hspV0 
expression was highly inducible in sparse cells (not shown) and 
the extent of expression was dependent on the concentration 
of Ox-LDL during the challenge (Fig. 2). 
In order to confirm the above observations with smooth 
muscle cells of different origin, we performed immunofluores- 
cence experiments with the A-617 smooth muscle cell line de- 
rived from human femoral artery. However, only a weak induc- 
tion of hspV0 was observed when the cells were incubated with 
Ox-LDL up to 400/zg/ml (Fig. 3a,b). In the same experimental 
conditions, HUVSMC displayed very strong staining for hspV0 
(Fig. 3c,d). Upon staining for smooth muscle cx-actin, 
HUVSMC showed an intense fluorescence, with well organized 
c~-actin bundles, while the A-617 SMC line only showed a faint 
staining (Fig. 3e,f). On the contrary, upon staining for fl-actin 
HUVSMC showed weak staining and the A-617 SMC line 
displayed a relatively strong fluorescence (Fig. 3g,h). The re- 
sults of an MTT test showed that, when cells were in sparse 
culture, Ox-LDL were toxic to both HUVSMC and, to a larger 
extent, to the A-617 SMC line (Fig. 4). 
4. Discussion 
De novo synthesis of stress proteins is generally regarded as 
a defense response triggered by toxic environmental conditions 
[1], and cytoprotection provided by hsps appears to be relevant 
in several pathologies [15]. Hsps may have a role also in athero- 
sclerosis, since increased expression of hspV0 has been observed 
in human atherosclerotic lesions [4-6]. Recently, we reported 
that Ox-LDL, a cytotoxic lipoprotein, induce the expression of 
hspV0 in cultured human endothelial cells; we speculated that, 
in vivo, the presence of Ox-LDL might induce the expression 
of hsp70, possibly a cytoprotective r sponse of arterial wall 
cells [3]. Oxidized LDL are thought o be a causal factor in 
atherosclerosis, and they have been detected in human and 
animal esions [16]. In vitro, and most likely in vivo, Ox-LDL 
can damage smooth muscle cells, a major component of fibrous 
plaques in atherosclerotic lesions. Toxicity to smooth muscle 
cells is believed to represent an important atherogenic factor, 
since these cells are lost from deep- to mid-intimal locations 
during the development of the lipid-rich core of atherosclerotic 
plaques [17]. The finding that Ox-LDL induce the expression 
of hspV0 in cultured A-617 SMC as well as in endothelial cells 
reinforces the hypothesis that these lipoproteins may trigger a 
defense response in cells of the arterial wall. This may confer 
a relative resistance to repeated challengles ustained (driven) 
by Ox-LDL or, possibly, other toxic. Indeed, survival of 
smooth muscle cells to cytotoxic onditions is significantly im- 
proved by heat shock [6] or by a pretreatment with exogenous 
hspV0 [6,18]. Preliminary data in our laboratory also indicate 
that induction of hsp70 expression in human endothelial cells 
confers protection against highly toxic and potentially lethal 
concentrations of Ox-LDL (unpublished observations). As it 
occurs in several diseases [19] oxidation appears to be involved 
in atherosclerosis [20] and the use of antioxidants has proved 
beneficial for the prevention or the correction of experimental 
[21] and clinical [22] atherosclerosis. The oxidative burst associ- 
ated with ischemia/reperfusion increases the expression of 
hsp70 [23] and, accordingly, induction of hspV0 expression pro- 
tects from ischemia/reperfusion injury [24]. The balance be- 
tween proatherogenic insults (i.e. Ox-LDL toxicity) and the 
ability of the cell to cope with them (i.e. stress response) can 
influence the evolution of atherosclerotic lesions. In the pres- 
ence of Ox-LDL, confluent HUVSMC express much less hsp70 
than sparse ones. Accordingly, wounding experiment indicated 
that actively dividing or/and migrating smooth muscle cells (i.e. 
sparse cells) are much more sensitive to Ox-LDL than relatively 
stationary cells (i.e. confluent cells). Consistent results were 
obtained in wounded endothelial cells that had been labeled 
with BrdU before the addition of Ox-LDL. Double im- 
munofluorescence staining indicated in fact that the majority 
of cells at the boundary of the injury area expressed hspV0 and 
were BrdU positive (data not shown). That is, actively cycling 
cells are most sensitive to the stress. 
It is generally accepted that smooth muscle cell proliferation 
and migration from the arterial tunica media into the intima are 
essential steps in the development of atheromatous plaque [25 
28]. The present results may be relevant o the understanding 
of smooth muscle cell response to injury in proatherosclerotic 
events. 
The comparison between HUVSMC and the A-617 SMC line 
offered some interesting information. Differently from 
HUVSMC, the SMC line showed very weak hsp70 expression 
even at a high concentration of Ox-LDL, although Ox-LDL 
were cytotoxic to both types of cell. Interestingly, HUVSMC 
were damaged by Ox-LDL less than the A-617 SMC line was. 
We do not know whether this may relate to the higher expres- 
sion of hsp70, a cytoprotective protein, in HUVSMC. 
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HUVSMC, which were used between the 1st and 3rd passage 
after isolation, displayed a strong staining for e-actin and low 
staining for fl-actin, while the permanent A-617 SMC line dis- 
played a faint staining for ~-actin and a relatively strong stain- 
ing for fl-actin. Since phenotypic hanges in smooth muscle 
cells are associated with changes in the relative expression of 
actin isoforms [29,30]. This might be a very important issue 
since development of atherosclerotic plaques is characterized 
by the transition of SMC phenotype from a contractile to a 
synthetic one [31 33]. Further experiments are needed to con- 
firm this hypothesis. 
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